I work 7 days/week and have 7-10 hats so i dont feel like

New Post Public Reply Private Reply Replies (2) Message Board
microcaps Sierra #8114
530
I work 7 days/week and have 7-10 hats so i dont feel like researching the post I've been thinking of for many years- the last time I tried to explain the benefits of upgrading (and i've explained many times why they probably havent upgraded til now) I got heavy backlash from longs as if i was attacking the company!!!!!!!!!!!!!!!!!!

longs continually -if pps isnt currently rising-complain about the long term pps fall -which is NORMAL for no info co's for the many reasons I explained years ago and have explained again recently because sec otc etc is changing the game and requiring more transparency again-as they will keep doing.

Then as well as now most posts -including longs posts-show they dont understand what i'm saying. One of my hats is as an expository writer who explores a problem from many angles to open peoples eyes. Yet all my life I 've seen very few understand despite using simple language.

Instead of trying to understand many will simply attack as longs did many years ago. One long even said how did the moderator become the biggest basher on the board. To my memory Sierra that long was you.
So as i continue to get more kickback against my explanations from you than any other long it gives me the strong impression that you oppose the idea of NNLX upgrading at this time.
Yes you say WHEN NNLX has the commercial partner then it will be ok- but i've been trying to explain inter alia how the 'no info' class has hindered/hurt NNLX from obtaining partners or licensees etc.

E.g NNLX went to a lot of effort for years to obtain a european wide patent for the petri dishes-an effort which cost them a lot more than upgrading- and yet if the companies who received NNLX's solicitation tried to research NNLX (outside the website which wasnt then current?) they would be flabbergasted by the 'no info' status-which almost completely contradicts NNLX's accomplishments and which would cause companies to question NNLX's accomplishments and patents and purposes(witnessing otc's scary language re no info co's) because companies with those accomplishments and patents as i've explained before are NOT 'no info' status.

I feel like i hit a brick wall in trying to get longs to understand the benefits of upgrading on this board- BY FAR the most difificult and bizarre board i've ever moderated. I know the big reason why and have written hundreds of books and articles re that reason-but suffice it to say if people dont understand the simple points I've been making re the benefits of upgrading they will not understand the why of why they dont understand those points.

one of my past posts re this issue is below- one day i rebutted the below serial basher ca 32 times in that day and somebody even excitedly said something like, 'wow, have we just witnessed an intellectual discussion on this board?'




Posted On: 12/20/2014 10:44:29 PM Replies (3)
Avatar
Posted By: microcaps #1012
Re: pumpkinsherrie #1010
Even the manipulated understated practically useless twice monthly short report which gives mm's days and 12 ways (see 4kids9pets and 7-10-11's posts) to hide true shorts shows the following shorts

Nov 28, 2014 110,177 shorts 1,008.76 173,009 total volume

you completely misunderstand my posts

the penalties are for remaining non pink current when they transition to significant revenue because otc thinks any co that fails to upgrade to pink current is deceiving holders-so they clap ce on hundreds of such co's,and then other entities join the free for all

i've detailed those widespread commonly employed otc penalties at length before so research my posts
there are no otc penalties for failure to uplist- which is different than upgrading - from pink current to OTCQB

but the stock market via investor choice/comfort level levies a penalty on co's -the lower the stock classification on otc or otcqb vs OTCQX or big boards etc the greater the investor penalty and the smaller the investor pool and thus the lower the buy sell ratio- which is why non-current co's especially systemically have had a downward pps spiral since sept 2009

which is why the very very few market savvy penny ceos now upgrade in the new anti non-current political reality and or uplist to the highest classification they can afford- it brings net benefits by increasing investor pool, liquidity and thus pps increase over what pps would have been at a lower classification, esp because shorters target non current classes for many reasons-in short because such stocks have a 95% plus chance of pps decline,

in the last year the stock market has risen-blue chips on big boards have risen
blue chips -mostly foreign blues-have done less well on OTCQX- which has the same essential reporting standards as big boards but is less well known and many brokers dont even know about OTCQX-begun in 2009 because otc keeps raising requirements in a highly fluid situation and pushing co's to increase the level of their status- which is the next uplisting above OTCQB

meanwhile OTCQB co's -though SEC reporting and thus big boys -institutions can invest in such-have had a much harder time due to smaller investor pool and more shorters

and pinks have a much smaller investor pool than otcqb,esp limited info and no info

by the time u get down to no info status the investor pool is limited to core longs against a bevy of mad shorters bashers day traders technical traders -and when there are ebola PR's etc promo players/day traders who siphon money-such promos end up hurting co's pps in long term

thus i;m just saying the best and cheapest way the co can improve outlook and investor pool and buy sell ratio and long/shorter ratio and thus pps is by upgrading while preparing to uplist to OTCQB-they may be in the process of doing so-i dont know

NNLX current pps w their game changing technology ,ongoing and upcoming catalysts and financials -compared to other co's at this pps -is a steal -
but nobody but core longs know that because the investor pool is so small in the no info class in the current environment and investors can see no info on NNLX at otc so they wont even know about NNLX because they arent going to dig deep enough to find the website when they have no reason to do so re a no info co when there are thousands of current pinks plus OTCQB who are advertising their financials and their game plan via 10Q's and 10 K's

again NOT NOT attacking the co in any way-explaining systemic penny market realities and what NNLX needs to do imo from very hard experience ( 250,000 worth) to protect longs and the co and stop the non-intrinsic value pps slide that is experienced by 95-99% of no info co's,

co's need to change their otc status w the rapidly changing penny market,especially in their transition from development stage to significant revenues or otc will do the changing for them

their is a strong unconstitutional anti-business political push to eliminate no info co's - which has affected several thousands of pennies since 2009 via broker/dtc restrictions and to slap them all w a ce which otc does at a drop of a hat in the current political environment
thats why to eliminate a ce otc and dtc and brokers REQUIRE an upgrade to pink current and why dtc has attacked countless non-current co's without due process despite dtc's Nov 2013 whitepaper under pressure by congress to grant a semblance of due process

they are also trying to eliminate pps below 1c -they are trying to force all non current pennies to upgrade-so its much cheaper for co's to do so on their own initiative than wait for the tagteam gauntlet of penalties

Read More: https://investorshangout.com/post/postreplies...z6qr4WWtPD

Nanologix Inc (NNLX) Stock Research Links

NNLX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elong Kicks Off Central Asia Strategy with Almaty Launch

Updated Category News Views 70

Elong's Strategic Move into Central Asia When a company like Elong Hotel Technology decides to plant its flag in Central Asia, it’s more than just another overseas venture. This brand launch in Almaty is a bold statement—a signal that they're here to shake things up in a region ripe for development but lacking in hotel chains. With only about 20% penetration for local...

Continue Reading
AptarGroup Faces Investigation: Shareholder Stakes High

Updated Category News Views 89

AptarGroup Directors Under Investigation Every seasoned investor knows the market isn’t just sunshine and rainbows. Lately, the storm clouds have gathered over AptarGroup, Inc. (NYSE: ATR). Out of nowhere comes Purcell & Lefkowitz LLP, announcing a shareholder investigation that sends shivers down the spines of those who've put their money on this packaging...

Continue Reading
24X Partners with Standard Chartered for Crypto Leap

Updated Category News Views 86

24X Steps Up the Game with Crypto Addition You gotta give it to 24X—they're not just twiddling their thumbs in the background. These folks in Bermuda have snagged another feather in their cap by expanding their partnership with heavyweight Standard Chartered, bringing Bitcoin and Ethereum into the mix. We're talking big moves here as 24X becomes the first to offer...

Continue Reading
Cloud Software Group's $2B Debt Offer Wraps Up

Updated Category News Views 191

Sizing Up Cloud Software Group’s Recent Maneuver Whoever thought navigating debt was a dull spectacle hasn’t kept up with Cloud Software Group's recent financial theatrics. With a $2 billion cap on the table, their cash tender offer for 9.00% Senior Secured Second Lien Notes due 2029 didn’t just happen; it paraded onto the financial stage and left a noteworthy...

Continue Reading
Sino Biological Boosts AI Protein Discovery Efficiency

Updated Category News Views 37

Dissecting the Bridge Between AI and Biology In the cutthroat world of biotech, every second counts. Sino Biological is taking a good hard look at bridging AI and practical applications with their shiny new 4RISE™ solution. The stakes couldn't be higher—turning computer-generated protein ideas into lab-tested realities is no small feat. And believe me, researchers...

Continue Reading
VT Markets Unites Trading and Drama in New Finale

Updated Category News Views 76

Trading Meets Reality Show Drama Just when you thought you'd seen it all in the trading world, VT Markets rolls out a new spectacle. They're launching the Gold Cup 2026, an unscripted reality show stuffed with enough drama and tension to keep any trader on the edge of their seat. This isn't your run-of-the-mill trading competition; this is an injection of pure adrenaline...

Continue Reading
Poland's Economic Boom: A Case for Freedom and Growth

Updated Category News Views 60

Poland's Remarkable Journey to Economic Power Freedom, they say, fuels progress—and Poland stands as a pulsating testament to that very idea. Thirty-odd years ago, shedding the chains of Soviet-imposed communism, Poland was all systems go, taking the wheel of its own destiny. For the first time, Polish innovation and industry were unleashed, paving the road toward...

Continue Reading
Quantinuum & RIKEN Propel Japan's Quantum Leap Forward

Updated Category News Views 81

Quantum Computing: Japan's Bold New Frontier Quantum computing's buzz is getting louder, and the big players like Quantinuum and RIKEN ain't sitting on their hands. They've rolled up their sleeves to ramp up Japan's quantum-AI supercomputing game with the recent beef-up of Quantinuum's Reimei to its H2 system, putting Japan at the cutting edge of hybrid computing. The...

Continue Reading
AION Labs Elevates Leadership, Eyes New R&D Horizons

Updated Category News Views 70

Setting New Standards in Pharma Innovation The air in Rehovot, Israel might be filled with more than just technological aspirations, thanks to AION Labs stepping up its leadership game. This venture studio doesn't seem content to rest on its laurels. Nope, it's diving headlong into the deeper end of pharma R&D, scouting out fresh tech territories like quantum computing...

Continue Reading
1-800Accountant Secures Global Win in Tax Services

Updated Category News Views 53

Another Feather in the Cap for 1-800Accountant You don’t get to be at the top of your game without turning a few heads. And 1-800Accountant has done just that, snagging the Fall 2026 Clutch Global Award for their expertise in the accounting universe. The Importance of Listening In this day and age, businesses large and small are realizing that the voice of the client is...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Fundraising Campaign to Restore Food Bank Services

Updated Category News Views 160

Transforming Community Support Through Art and Action In the wake of devastating wildfires that impacted a significant area, a new initiative is taking shape to assist those affected. This unique campaign combines the power of art and activism to address an urgent community need: the restoration of a food bank that has served countless families over the past two decades....

Continue Reading
OYO Expands Horizons with Acquisition of G6 Hospitality

Updated Category News Views 67

OYO Acquires G6 Hospitality: A Major Strategic Move In a significant development, Oravel Stays, the parent company of OYO, has announced its acquisition of G6 Hospitality from Blackstone Real Estate for $525 million. This all-cash deal aims to strengthen OYO's presence in the U.S. hospitality industry. Growing Presence in the United States Since diving into the U.S....

Continue Reading
Dizal's Sunvozertinib Receives FDA Priority Review for NSCLC

Updated Category News Views 262

FDA's Priority Review of Sunvozertinib: A Game Changer for NSCLC Dizal is making headlines with the announcement that the U.S. Food and Drug Administration (FDA) has granted priority review for the company's New Drug Application (NDA) for Sunvozertinib. This oral EGFR inhibitor holds the promise of offering a significant treatment option for patients suffering from...

Continue Reading
Deep Dive into Masimo Corporation's Ongoing Legal Troubles

Updated Category News Views 294

Masimo Corporation Under Scrutiny Recently, the spotlight has turned to Masimo Corporation (NASDAQ: MASI) as investigations unfold regarding potential misconduct among its leadership. The inquiry is spearheaded by Charles C. Foti, Jr., a former Attorney General of Louisiana and partner at Kahn Swick & Foti, LLC. Revenue Shortfalls and Investor Concerns The company faced a...

Continue Reading
PMV Pharmaceuticals Unveils Promising Monotherapy Data for Solid Tumors

Updated Category News Views 471

Exciting Developments in Cancer Treatment In the realm of precision oncology, PMV Pharmaceuticals continues to lead the charge with groundbreaking research that shines a spotlight on novel therapies. Today, the company has presented updated interim data that promises to reshape the treatment landscape for patients dealing with advanced solid tumors, particularly those...

Continue Reading